Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > it was March/29/22 when THRM submitted
View:
Post by dmshediac on Dec 03, 2022 9:13am

it was March/29/22 when THRM submitted

to FDA  , after doing the field study, gathering & annalyzing the data, etc.. The process started long ago but it is a process to gather all the data. The NR states that FDA does not give time lines. I  don't know and sure none of us know how many stages/reviews the FDA will do for this type approval. Obviously if it was a new drug it would very, very long,,,,   side effects, long term effects etc, lots of studies would have to  be done.
Comment by terr2 on Dec 03, 2022 10:54am
You have to realize that the FDA is by far away one of the most corrupt entity's in the United States. They don't do anything unless there are incentives involved and believe me that's what the lobbyist for big pharma do and do well. Small one man Canadian shows don't have much chance. AJMO
Comment by hk1966 on Dec 05, 2022 4:02pm
And you are speaking from "personal " experience? So who did you bribe then? Do ell inquiring minds want to know.  really? What another azz clown here!  reported for slander
Comment by Knewbie on Dec 05, 2022 7:11pm
slan·der /slandr/ Learn to pronounce   noun LAW the action or crime of making a false spoken statement damaging to a person's reputation. "he is suing the TV network for slander"  ...more  
Comment by spygate on Dec 05, 2022 8:35am
its not a new drug...it is not a drug at all...what side effects could possible result from a test? dry mouth from spitting too much? cmon man, you are grasping...EAU is supposed to fast track approvals, it was not March it was July 2021 that they first submitted unless that was a lie as well? Maybe Rob will post the FDA tracking # that was received? its become more and more apparant that things ...more  
Comment by Knewbie on Dec 05, 2022 10:22am
NOTTA AGAIN THIS WEEK!!! POS CEO IS DOING NOTHING ABOUT IT!!  MAYBE HE THINKS WE WILL JUST FORGET ABOUT IT AND MOVE ON!!!  WHAT ARE YOU DOING ROB!!!! ??????? 
Comment by Elguyu1 on Dec 05, 2022 4:03pm
I do not think that Fia will have any chose but to depend on sales of Venowave and maybe a couple of his other products to get the millions of dollars it will take to get his new project to market.Iam sure he would prefer a reverse split and then go to the market for another PP. His trouble is who would buy it as anyone who ever has bought one of his PP  has lost his money  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities